A Crossover Safety Study of Ferumoxytol Versus Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

August 31, 2006

Conditions
Anemia
Interventions
DRUG

ferumoxytol or placebo

Trial Locations (41)

10016

New York

10029

New York

11355

Flushing

14127

Orchard Park

16176

Erie

17604

Lancaster

20814

Bethesda

20854

Washington D.C.

22304

Alexandria

22908

Charlottesville

23320

Chesapeake

23507

Norfolk

24701

Bluefield

27609

Raleigh

29150

Sumter

29605

Greenville

30265

Newnan

30308

Atlanta

30901

Augusta

33614

Tampa

34471

Ocala

36608

Mobile

37404

Chattanooga

37923

Knoxville

43210

Columbus

48236

Detroit

54911

Appleton

61603

Peoria

63136

St Louis

68822

Broken Bow

71101

Shreveport

71103

Shreveport

77074

Houston

78212

San Antonio

78758

Austin

85012

Phoenix

94041

Mountain View

97213

Portland

06511

New Haven

02135

Boston

03756

Lebanon

Sponsors
All Listed Sponsors
lead

AMAG Pharmaceuticals, Inc.

INDUSTRY